Dihydroergotine Mesylate Extended-Release Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dihydroergotine Mesylate Extended-Release Tablets, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease. [Phase 4]